Literature DB >> 25665815

Optimum BMI cut points to screen asian americans for type 2 diabetes.

Maria Rosario G Araneta1, Alka M Kanaya2, William C Hsu3, Healani K Chang4, Andrew Grandinetti4, Edward J Boyko5, Tomoshige Hayashi6, Steven E Kahn7, Donna L Leonetti8, Marguerite J McNeely9, Yukiko Onishi10, Kyoko K Sato6, Wilfred Y Fujimoto9.   

Abstract

OBJECTIVE: Asian Americans manifest type 2 diabetes at low BMI levels but may not undergo diagnostic testing for diabetes if the currently recommended BMI screening cut point of ≥25 kg/m(2) is followed. We aimed to ascertain an appropriate lower BMI cut point among Asian-American adults without a prior diabetes diagnosis. RESEARCH DESIGN AND METHODS: We consolidated data from 1,663 participants, ages ≥45 years, without a prior diabetes diagnosis, from population- and community-based studies, including the Mediators of Atherosclerosis in South Asians Living in America study, the North Kohala Study, the Seattle Japanese American Community Diabetes Study, and the University of California San Diego Filipino Health Study. Clinical measures included a 2-h 75-g oral glucose tolerance test, BMI, and glycosylated hemoglobin (HbA1c).
RESULTS: Mean age was 59.7 years, mean BMI was 25.4 kg/m(2), 58% were women, and type 2 diabetes prevalence (American Diabetes Association 2010 criteria) was 16.9%. At BMI ≥25 kg/m(2), sensitivity (63.7%), specificity (52.8%), and Youden index (0.16) values were low; limiting screening to BMI ≥25 kg/m(2) would miss 36% of Asian Americans with type 2 diabetes. For screening purposes, higher sensitivity is desirable to minimize missing cases, especially if the diagnostic test is relatively simple and inexpensive. At BMI ≥23 kg/m(2), sensitivity (84.7%) was high in the total sample and by sex and Asian-American subgroup and would miss only ∼15% of Asian Americans with diabetes.
CONCLUSIONS: The BMI cut point for identifying Asian Americans who should be screened for undiagnosed type 2 diabetes should be <25 kg/m(2), and ≥23 kg/m(2) may be the most practical.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25665815      PMCID: PMC4407753          DOI: 10.2337/dc14-2071

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  21 in total

1.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population.

Authors:  Maria Rosario G Araneta; Deborah L Wingard; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

3.  A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians.

Authors:  Maria Rosario G Araneta; Andrew Grandinetti; Healani K Chang
Journal:  Diabetes Care       Date:  2010-09-10       Impact factor: 19.112

4.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 5.  A systematic review of overweight, obesity, and type 2 diabetes among Asian American subgroups.

Authors:  Lisa R Staimez; Mary Beth Weber; K M Venkat Narayan; Reena Oza-Frank
Journal:  Curr Diabetes Rev       Date:  2013-07

6.  Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance.

Authors:  W Y Fujimoto; R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

7.  Glucose intolerance and diabetic complications among Japanese-American women.

Authors:  W Y Fujimoto; D L Leonetti; R W Bergstrom; J L Kinyoun; W C Stolov; P W Wahl
Journal:  Diabetes Res Clin Pract       Date:  1991-08       Impact factor: 5.602

8.  Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK biobank participants.

Authors:  Uduakobong E Ntuk; Jason M R Gill; Daniel F Mackay; Naveed Sattar; Jill P Pell
Journal:  Diabetes Care       Date:  2014-06-29       Impact factor: 19.112

9.  Elevated rates of diabetes in Pacific Islanders and Asian subgroups: The Diabetes Study of Northern California (DISTANCE).

Authors:  Andrew J Karter; Dean Schillinger; Alyce S Adams; Howard H Moffet; Jennifer Liu; Nancy E Adler; Alka M Kanaya
Journal:  Diabetes Care       Date:  2012-10-15       Impact factor: 19.112

10.  Mediators of Atherosclerosis in South Asians Living in America (MASALA) study: objectives, methods, and cohort description.

Authors:  Alka M Kanaya; Namratha Kandula; David Herrington; Matthew J Budoff; Stephen Hulley; Eric Vittinghoff; Kiang Liu
Journal:  Clin Cardiol       Date:  2013-11-05       Impact factor: 2.882

View more
  51 in total

1.  Accuracy of body weight perception and obesity among Chinese Americans.

Authors:  Shan Liu; Mei R Fu; Sophia H Hu; Vincent Y Wang; Robert Crupi; Jeanna M Qiu; Chuck Cleland; Gail D'Eramo Melkus
Journal:  Obes Res Clin Pract       Date:  2015-04-30       Impact factor: 2.288

2.  Educational Interventions to Promote Healthy Nutrition and Physical Activity Among Older Chinese Americans: A Cluster-Randomized Trial.

Authors:  Jane Jih; Gem Le; Kent Woo; Janice Y Tsoh; Susan Stewart; Ginny Gildengorin; Adam Burke; Ching Wong; Elaine Chan; Lei-Chun Fung; Filmer Yu; Rena Pasick; Stephen J McPhee; Tung T Nguyen
Journal:  Am J Public Health       Date:  2016-03-17       Impact factor: 9.308

3.  High frequency of the PNPLA3 rs738409 [G] single-nucleotide polymorphism in Hmong individuals as a potential basis for a predisposition to chronic liver disease.

Authors:  Clifford G Tepper; Julie H T Dang; Susan L Stewart; Dao M Fang; Kimberly A Wong; Stephenie Y Liu; Ryan R Davis; Doan Y Dao; Jeffrey P Gregg; Natalie J Török; Moon S Chen
Journal:  Cancer       Date:  2018-04-01       Impact factor: 6.860

4.  The obesity paradox, extreme obesity, and long-term outcomes in older adults with ST-segment elevation myocardial infarction: results from the NCDR.

Authors:  Ian J Neeland; Sandeep R Das; DaJuanicia N Simon; Deborah B Diercks; Karen P Alexander; Tracy Y Wang; James A de Lemos
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-07-01

Review 5.  Diabetes Among Non-Overweight Individuals: an Emerging Public Health Challenge.

Authors:  Unjali P Gujral; Mary Beth Weber; Lisa R Staimez; K M Venkat Narayan
Journal:  Curr Diab Rep       Date:  2018-07-04       Impact factor: 4.810

6.  An Exercise Intervention for South Asian Mothers with Risk Factors for Diabetes.

Authors:  Namratha R Kandula; Swapna Dave; Peter John De Chavez; David X Marquez; Himali Bharucha; Shinu Mammen; Andrea Dunaif; Ronald T Ackermann; Santosh Kumar; Juned Siddique
Journal:  Transl J Am Coll Sports Med       Date:  2016-06-15

7.  Diabetes Prevalence and Risk Factors in Four Asian American Communities.

Authors:  Susan L Stewart; Julie Dang; Moon S Chen
Journal:  J Community Health       Date:  2016-12

Review 8.  Type II diabetes disparities in diverse women: the potential roles of body composition, diet and physical activity.

Authors:  Margaret A Crawford; Andrea S Mendoza-Vasconez; Britta A Larsen
Journal:  Womens Health (Lond)       Date:  2015-12-09

Review 9.  Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management.

Authors:  Ian J Neeland; Paul Poirier; Jean-Pierre Després
Journal:  Circulation       Date:  2018-03-27       Impact factor: 29.690

10.  The South Asian Healthy Lifestyle Intervention (SAHELI) trial: Protocol for a mixed-methods, hybrid effectiveness implementation trial for reducing cardiovascular risk in South Asians in the United States.

Authors:  Namratha R Kandula; Veronica Bernard; Swapna Dave; Linda Ehrlich-Jones; Catherine Counard; Nirav Shah; Santosh Kumar; Goutham Rao; Ronald Ackermann; Bonnie Spring; Juned Siddique
Journal:  Contemp Clin Trials       Date:  2020-03-24       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.